ImmuCell Corporation Increase (Decrease) in Accounts Payable
ImmuCell Corporation (ICCC) reported Increase (Decrease) in Accounts Payable of $4.83 thousand for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2014-11-12
- ImmuCell Corporation increase (decrease) in accounts payable for the quarter ending 2014-09-30 was -$10.55K.
- ImmuCell Corporation increase (decrease) in accounts payable for the quarter ending 2014-06-30 was -$6.61K, a 141.85% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accounts payable for the quarter ending 2014-03-31 was $21.99K.
- ImmuCell Corporation increase (decrease) in accounts payable for the quarter ending 2013-12-31 was $35.03K, a 40.54% decline year-over-year.
- ImmuCell Corporation increase (decrease) in accounts payable for fiscal 2013 was -$95.50K, a 195.46% decline from fiscal 2012.
- ImmuCell Corporation increase (decrease) in accounts payable for fiscal 2012 was $100.05K, a 68.21% increase from fiscal 2011.
- ImmuCell Corporation increase (decrease) in accounts payable for fiscal 2011 was $59.48K.
- ImmuCell Corporation increase (decrease) in accounts payable for fiscal 2010 was -$26.81K, a 189.41% decline from fiscal 2009.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month | Increase (Decrease) in Accounts Payable 12 month |
|---|---|---|---|---|
| 2014-09-30 | -$10.55K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$17.16K derived: sum of 2 quarters · filed 2014-11-12 | $4.83K 10-Q · filed 2014-11-12 | $39.86K derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-06-30 | -$6.61K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | $15.38K 10-Q · filed 2014-08-13 | $50.41K derived: sum of 3 quarters · filed 2014-08-13 | -$27.41K derived: sum of 4 quarters · filed 2014-11-12 |
| 2014-03-31 | $21.99K 10-Q · filed 2014-05-14 | $57.02K derived: sum of 2 quarters · filed 2014-05-14 | -$20.80K derived: sum of 3 quarters · filed 2014-11-12 | -$5.00K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-12-31 | $35.03K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | -$42.79K derived: sum of 2 quarters · filed 2014-11-12 | -$26.99K derived: sum of 3 quarters · filed 2014-11-12 | -$95.50K 10-K · filed 2014-03-26 |
| 2013-09-30 | -$77.82K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$62.02K derived: sum of 2 quarters · filed 2014-11-12 | -$130.53K 10-Q · filed 2014-11-12 | -$71.62K derived: sum of 4 quarters · filed 2014-11-12 |
| 2013-06-30 | $15.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$52.72K 10-Q · filed 2014-08-13 | $6.19K derived: sum of 3 quarters · filed 2014-08-13 | $61.25K derived: sum of 4 quarters · filed 2014-08-13 |
| 2013-03-31 | -$68.51K 10-Q · filed 2014-05-14 | -$9.60K derived: sum of 2 quarters · filed 2014-05-14 | $45.46K derived: sum of 3 quarters · filed 2014-05-14 | -$47.89K derived: sum of 4 quarters · filed 2014-05-14 |
| 2012-12-31 | $58.91K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $113.97K derived: sum of 2 quarters · filed 2014-03-26 | $20.62K derived: sum of 3 quarters · filed 2014-03-26 | $100.05K 10-K · filed 2014-03-26 |
| 2012-09-30 | $55.06K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | -$38.29K derived: sum of 2 quarters · filed 2013-11-13 | $41.14K 10-Q · filed 2013-11-13 | $68.87K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-06-30 | -$93.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-13 | -$13.92K 10-Q · filed 2013-08-13 | $13.81K derived: sum of 3 quarters · filed 2014-03-26 | $67.33K derived: sum of 4 quarters · filed 2014-03-26 |
| 2012-03-31 | $79.43K 10-Q · filed 2013-05-14 | $107.16K derived: sum of 2 quarters · filed 2014-03-26 | $160.68K derived: sum of 3 quarters · filed 2014-03-26 | $93.97K derived: sum of 4 quarters · filed 2014-03-26 |
| 2011-12-31 | $27.73K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-26 | $81.25K derived: sum of 2 quarters · filed 2014-03-26 | $14.54K derived: sum of 3 quarters · filed 2014-03-26 | $59.48K 10-K · filed 2014-03-26 |
| 2011-09-30 | $53.52K derived: 10-Q 9 month − 10-Q/A 6 month · filed 2012-11-13 | -$13.20K derived: sum of 2 quarters · filed 2012-11-13 | $31.75K 10-Q · filed 2012-11-13 | -$38.13K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-06-30 | -$66.72K derived: 10-Q/A 6 month − 10-Q 3 month · filed 2012-09-07 | -$21.77K 10-Q/A · filed 2012-09-07 | -$91.65K derived: sum of 3 quarters · filed 2013-03-28 | -$35.66K derived: sum of 4 quarters · filed 2013-03-28 |
| 2011-03-31 | $44.94K 10-Q · filed 2012-05-14 | -$24.93K derived: sum of 2 quarters · filed 2013-03-28 | $31.05K derived: sum of 3 quarters · filed 2013-03-28 | |
| 2010-12-31 | -$69.88K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | -$13.89K derived: sum of 2 quarters · filed 2013-03-28 | -$26.81K 10-K · filed 2013-03-28 | |
| 2010-09-30 | $55.99K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $43.07K 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | -$12.92K 10-Q · filed 2011-08-15 | |||
| 2009-12-31 | $29.98K 10-K · filed 2012-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |